🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the USA / NCT07294482
Recruiting Not applicable

The Effects on Sleep Quality of 1:4 Reishi Liquid Extract

NCT07294482 · tracked via the Priya Life Science USA tracker
Sponsor
Efforia, Inc
Phase
Not applicable
Started
2025-09-10
Last updated
2025-12-26

Condition(s) studied

Sleep

Investigational drug(s) / intervention(s)

Bristol Fungarium's 1:4 Reishi Mushroom Tincture

Bristol Fungarium's 1:4 Reishi Mushroom Tincture: UK-grown organic Reishi tincture, cloned in lab. Triple Extracted, 1: 4 Ratio via two hot water extractions and a final organic ethanol extraction to gain access to all the bioactive compounds responsible for Reishi's beneficial properties. (1g of mushrooms to every 4ml of water).

Study summary

Examining the effects of 1ml of Reishi mushroom extract (1:4 extraction ratio, two hot water extractions and an alcohol extraction), taken daily, 30 mins before bed on perceived sleep quality and stress levels. Sleep quality includes: duration, sleep onset latency, nighttime wakings, and perceived restfulness. And consequently, the potential for increased daytime energy levels and a reduction in perceived stress levels.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Can read and understand English. * US resident. * Willing and able to follow the requirements of the protocol. Exclusion Criteria: * Individuals with Allergies * Pregnant or Nursing Women * Individuals on Anticoagulants * Immunocompromised Individuals * Individuals with Liver Disease * Children and Adolescents * Individuals with Chronic Illnesses * Those with Mental Health Disorders

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Efforia New York New York Recruiting

More Efforia, Inc trials in the USA

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07294482 on ClinicalTrials.gov ↗ ← All trials in the USA